Similar articles

• Clinical trials of combination therapies for HIV infection. Rationale for development of multidrug therapy.

  Hoth D. Hoth D. J Acquir Immune Defic Syndr (1988). 1990;3 Suppl 2:S95-6. J Acquir Immune Defic Syndr (1988). 1990. PMID: 2172506 No abstract available.
• [Anti-HIV therapy (1987-1994): from nothing to confusion].

  Lissen E. Lissen E. Med Clin (Barc). 1995 Apr 1;104(12):463-7. Med Clin (Barc). 1995. PMID: 7739285 Review. Spanish. No abstract available.
• [Inhibitors of HIV-1 reverse transcriptase and protease as chemotherapeutics for AIDS].

  Mitsuya H. Mitsuya H. Nihon Rinsho. 1991 Sep;49(9):2062-9. Nihon Rinsho. 1991. PMID: 1720470 Japanese. No abstract available.
• AZT delta study: major European/Australian study finds combinations better than AZT alone.

  King E. King E. AIDS Treat News. 1995 Oct 6;(no 232):3-4. AIDS Treat News. 1995. PMID: 11362876
• [Anti-retroviral treatment. Treatment modification: toxicity management].

  Ocaña I, Laguna F, Pulido F, Bascuñana A. Ocaña I, et al. Enferm Infecc Microbiol Clin. 1996 Oct;14 Suppl 1:31-5. Enferm Infecc Microbiol Clin. 1996. PMID: 9053025 Review. Spanish. No abstract available.